Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. The antibody portion is Belantamab , and the drug-linker conjugate for ADC is McMMAF . Belantamab mafodotin has anti-myeloma activity.